Investment Rating - The investment rating for the company is "Outperform the Market" [7] Core Insights - The company's core operating profit for 2025 increased by 48.2%, meeting expectations, with revenue reaching 7.81 billion yuan (+20.7%) and net profit attributable to shareholders at 430 million yuan (+87.8%) [1][8] - The company plans to expand its store network significantly, projecting over 14,500 stores by the end of 2026, with a net addition of over 2,934 stores, corresponding to a growth rate of over 25% [2][12] - The company has optimized its product structure and store displays to cater to the differentiated needs of the lower-tier market, resulting in a strong growth momentum in store efficiency and membership ecosystem [2][12] Financial Performance - In 2025, the company achieved a gross margin of 21.6% and a net margin of 5.8%, reflecting a steady improvement in profitability [3][13] - The company plans to distribute a total cash dividend of 290 million yuan in 2025, with a total dividend payout ratio of 67% [1][8] - The projected net profit for 2026 and 2027 has been revised upwards to 590 million yuan and 760 million yuan, respectively, indicating year-on-year growth rates of 36.8% and 29.1% [4][13] Store Expansion and Market Strategy - By the end of 2025, the total number of stores reached 11,566, with a net increase of 1,416 stores, including 1,004 new stores in rural areas [2][12] - The company has launched 282 new SKUs in 2025, with several popular meal packages driving sales growth [2][12] - The membership base grew to 64.9 million by the end of 2025, representing a year-on-year increase of 57.1% [2][12] Valuation Metrics - The current price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are projected at 15.7, 12.2, and 10.3 times, respectively [4][14] - The company’s return on equity (ROE) is expected to reach 19.1% in 2026, increasing to 25.9% by 2028 [5][15] - The projected revenue for 2026 is 9.91 billion yuan, reflecting a growth rate of 26.9% compared to 2025 [5][15]

Investment Rating - The investment rating for the company is "Buy-A" and is maintained [1][8] Core Views - The company is expected to achieve steady revenue growth for FY2026, continuing its high-quality operational performance despite a challenging external environment [4][6] - The brand's down jacket business is projected to show resilient growth, with mid-single-digit revenue growth anticipated, particularly for the main brand and the Snow Flying brand, which is expected to grow even faster [6] - The company has made strides in internationalization and high-end product offerings, exemplified by the launch of the AREAL series in Paris [6] - The private label processing business is under pressure due to tariffs and client operational challenges, with a forecasted revenue decline of 11.7% in FY2026H1 [7] - The women's wear and school uniform segments are expected to see double-digit declines, aligning with industry trends [7] Financial Performance and Forecast - For FY2026, the company is projected to generate revenues of 27.07 billion yuan, with a year-on-year growth of 4.5% [11] - Net profit forecasts for FY2026, FY2027, and FY2028 are 3.728 billion yuan, 3.997 billion yuan, and 4.286 billion yuan respectively, with corresponding P/E ratios of 11.9, 11.1, and 10.4 [8][11] - The gross margin is expected to remain stable around 57.5% for FY2026 [11] - The return on equity (ROE) is projected to be 20.8% for FY2026, slightly declining in subsequent years [11]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The report indicates that the commercialization pipeline is expected to confirm a sales turning point, with renewed emphasis on internationalization of the pipeline [3] - The company anticipates achieving revenue of USD 330-450 million in its oncology/immunology business for 2026, with projected revenues of CNY 46.89 billion, CNY 50.40 billion, and CNY 55.07 billion for 2026, 2027, and 2028 respectively [3][4] - The report highlights that the domestic sales of the drug Fuzuloparib are expected to improve significantly in the second half of 2025, driven by team restructuring and new indications being included in the medical insurance [3] Financial Projections - For 2024, the company is projected to have a revenue of CNY 4,530 million, with a year-over-year growth rate of -24% [1] - The net profit attributable to the parent company is expected to be CNY 271 million in 2024, with a significant increase to CNY 3,212 million in 2025, followed by CNY 459 million in 2026 [1] - The earnings per share (EPS) is projected to be CNY 0.31 in 2024, increasing to CNY 3.68 in 2025 and further to CNY 0.53 in 2026 [1] Market Performance - The report notes that the overseas market for Fuzuloparib is expected to continue its mid-to-high-speed growth, with sales projected at USD 370 million in 2025, reflecting a 26% year-over-year growth [3] - The report also mentions that the domestic sales of other drugs, such as Savolitinib and Sunitinib, are expected to see a narrowing decline in sales in the second half of 2025, indicating a potential stabilization in market competition [3] Pipeline Development - The report emphasizes the company's leadership in small molecule drug development, with ongoing internationalization of its pipeline, including the anticipated results from the SAFFRON trial for Savolitinib expected in mid-2026 [3] - The company is also advancing its ATTC projects, with clinical trials for new candidates expected to commence in 2026, indicating a robust pipeline for future growth [3]

Investment Rating - The report assigns a "Buy" rating to the company [4] Core Insights - The global social entertainment market is experiencing strong demand, with significant growth potential in the Middle East and North Africa (MENA) region, which is expected to see a compound annual growth rate (CAGR) of 9.4% from 2023 to 2028 [1][50] - The company employs a "bush" strategy to build competitive barriers, with a diverse product ecosystem that includes live social (MICO), voice social (YoHo), companionship social (SUGO), game social (TopTop), and various social products for different demographics [2] - AI empowerment and localized operations are key to establishing a long-term competitive advantage, with the company developing its own AI engine and establishing regional headquarters to tailor products to local cultures [3] Company Overview - The company is a global leader in social entertainment, with a multi-business growth strategy that includes social, gaming, short videos, and e-commerce [13] - The social business is the core revenue source, contributing approximately 89% of total revenue in the first half of 2025, while the innovative business, primarily focused on premium games, contributed about 11% [17] - The company has a strong governance structure, with the founder and key executives holding significant shares, ensuring alignment with long-term growth objectives [21] Financial Analysis - Revenue is projected to grow from 69.1 billion CNY in 2025 to 104.1 billion CNY in 2027, with net profit expected to increase from 9.13 billion CNY to 13.84 billion CNY during the same period [7] - The company’s gross margin has been stable, with a forecasted gross margin of 56.24% in 2025, reflecting the successful integration of innovative business lines [31] - The company’s earnings per share (EPS) is expected to rise from 0.65 CNY in 2025 to 0.98 CNY in 2027, indicating strong profitability growth [7] Industry Insights - The global mobile app market is thriving, with social networking and gaming apps leading in downloads, usage time, and monetization [41] - The MENA region is characterized by high consumer spending and a youthful demographic, with over 60% of the population under 35 years old, driving demand for social entertainment [50][52] - The internet penetration rate in the MENA region is nearly 100%, providing a solid foundation for social entertainment consumption [53]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report anticipates short-term performance pressure but remains optimistic about the smart terminal ecosystem benefiting from advancements in AI [1] - The company is expected to continue gaining market share in the high-end smartphone segment and its automotive business is projected to achieve profitability [1] - The report adjusts the forecast for net profit for 2025-2027 to 42.7 billion, 34.7 billion, and 37.4 billion respectively, reflecting the impact of rising storage prices [1] Financial Forecasts - Total revenue is projected to grow from 270.97 billion in 2023 to 549.22 billion by 2027, with a compound annual growth rate (CAGR) of approximately 10% [1] - Net profit is expected to increase significantly in 2024 by 606.34% year-on-year, followed by a growth of 35.38% in 2025, before experiencing a decline in 2026 [1] - The latest diluted EPS is forecasted to rise from 0.67 in 2023 to 1.43 in 2027, indicating a strong growth trajectory [1] Business Segments - **Smartphones**: The company is projected to maintain a global market share of 13.1% in Q4 2025, despite a forecasted decline in revenue due to rising storage costs [1] - **IoT and Consumer Products**: Revenue for this segment is expected to reach 126.4 billion in 2025, with a year-on-year growth of 21% [1] - **Internet Services**: Anticipated revenue growth of 10% in 2025, reaching 37.4 billion, with stable margins [1] - **Smart Automotive and Innovation**: The automotive segment is expected to see a revenue increase of over 200% in 2025, with a gross margin of 23% [1] Valuation Metrics - The price-to-earnings (P/E) ratio is projected to decrease from 43.87 in 2023 to 20.48 by 2027, indicating improved valuation as earnings grow [1] - The company is recognized as the largest consumer IoT platform globally, with significant long-term growth potential driven by AI integration [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company forecasts a revenue of 21.4 billion yuan for 2025, representing a year-on-year increase of 26%, slightly above the company's guidance of 25% [7] - The adjusted operating profit is expected to be around 3.67 billion yuan, in line with the previous guidance of 3.65 to 3.85 billion yuan [7] - The adjusted net profit is projected to be approximately 2.89 to 2.90 billion yuan, reflecting a year-on-year growth of 7%, which aligns with expectations [7] - The company has seen strong same-store sales growth, with a GMV increase of over 25% in January and February 2026, and over 50% growth in the U.S. market [7] - The report highlights the company's ongoing operational reforms that have positively impacted same-store performance [7] - The company is positioned as a leader in private label and IP trend retail, with significant growth potential in overseas expansion and IP strategy [7] Financial Summary - Total revenue projections for 2023A, 2024A, 2025E, 2026E, and 2027E are 11,473 million, 16,994 million, 21,439 million, 26,200 million, and 31,090 million yuan respectively, with year-on-year growth rates of 13.76%, 48.12%, 26.16%, 22.21%, and 18.66% [1] - The projected net profit for the parent company for the same years is 1,769 million, 2,618 million, 1,312 million, 3,194 million, and 4,061 million yuan, with year-on-year changes of 177.19%, 47.97%, (49.88)%, 143.45%, and 27.15% [1] - Non-IFRS net profit estimates are 2,357 million, 2,721 million, 2,898 million, 3,485 million, and 4,088 million yuan, with year-on-year growth rates of 109.65%, 15.44%, 6.54%, 20.22%, and 17.32% [1] - The latest diluted EPS for 2023A, 2024A, 2025E, 2026E, and 2027E are 1.43, 2.12, 1.06, 2.58, and 3.28 yuan respectively [1] - The P/E ratios based on the latest diluted EPS are 20.26, 13.69, 27.31, 11.22, and 8.82 for the respective years [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Insights - The company reported a revenue of $8.03 billion for 2025, a year-on-year decrease of 1.8%, with a net profit attributable to shareholders of $380 million, down 2.9% year-on-year. The manufacturing segment generated $5.65 billion in revenue, up 0.5% year-on-year, while the retail segment saw revenue decline to $2.38 billion, down 7.0% year-on-year [1][5] - The manufacturing business's average selling price (ASP) increased by 3.7% to $21.0, despite a slight decrease in shipment volume by 1.2% to 250 million pairs. The cautious ordering behavior from downstream brands due to tariffs and geopolitical uncertainties contributed to this decline [2][3] - The manufacturing gross margin decreased by 1.7 percentage points to 18.2%, primarily due to uneven capacity utilization and rising labor costs. However, the net profit margin for the manufacturing segment improved by 0.1 percentage points to 6.4% due to tax dispute reversals [3] - The retail segment faced challenges, with a 7.0% decline in revenue to $2.38 billion. Offline store sales were pressured by a 4.0% reduction in store count and double-digit same-store sales declines, while online retail showed resilience with over 30% revenue contribution [4] - The company is expected to see revenue growth in the coming years, with projections of $8.14 billion, $8.56 billion, and $9.01 billion for 2026, 2027, and 2028, respectively, reflecting year-on-year growth rates of 1.4%, 5.1%, and 5.3% [5][13] Summary by Sections Manufacturing Business - Revenue for the manufacturing segment was $5.65 billion, with a slight increase in ASP and a decrease in shipment volume [1][2] - The gross margin was impacted by uneven capacity utilization and rising costs, but net profit margin showed slight improvement [3] Retail Business - Retail revenue decreased to $2.38 billion, with offline sales underperforming while online sales remained strong [4] - The retail environment is expected to stabilize, with early signs of recovery in 2026 [4] Financial Forecast - The company is projected to achieve revenues of $8.14 billion, $8.56 billion, and $9.01 billion from 2026 to 2028, with corresponding net profits of $384 million, $415 million, and $450 million [5][13]

Investment Rating - The report maintains a "Buy" rating for the company [2][7] Core Insights - The company's performance met expectations with nearly doubled growth, projecting 2025 revenue between 2.40 billion to 2.45 billion RMB, a year-on-year increase of 98.3% to 102.5% [7] - The company focuses on high-end skincare using red camellia as a core ingredient, establishing itself as a benchmark in the oil-based skincare segment and continuously expanding its product line [7] - The company has a robust multi-channel strategy, enhancing its product matrix and user base, with significant growth in both offline and online channels [7] Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 805 million RMB - 2024: 1,210 million RMB - 2025E: 2,420 million RMB - 2026E: 3,199 million RMB - 2027E: 4,544 million RMB - Year-on-year growth rates for revenue are projected at 16% for 2023, 50% for 2024, 100% for 2025, 32% for 2026, and 42% for 2027 [6][8] - Net profit forecasts are as follows: - 2023: 84 million RMB - 2024: 187 million RMB - 2025E: 359 million RMB - 2026E: 579 million RMB - 2027E: 834 million RMB - Year-on-year growth rates for net profit are projected at 1540% for 2023, 121% for 2024, 92% for 2025, 61% for 2026, and 44% for 2027 [6][8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company forecasts a revenue of 21.4 billion yuan for 2025, representing a year-on-year increase of 26%, slightly above the company's guidance of 25% [7] - The adjusted net profit is expected to be around 2.89 to 2.90 billion yuan, reflecting a year-on-year growth of 7%, which aligns with expectations [7] - The company has seen strong same-store sales growth, with a GMV increase of over 25% in January and February 2026, indicating effective operational reforms [7] Financial Projections - Total revenue projections for the years 2023 to 2027 are as follows: - 2023: 11.47 billion yuan - 2024: 16.99 billion yuan - 2025: 21.44 billion yuan - 2026: 26.20 billion yuan - 2027: 31.09 billion yuan - Year-on-year growth rates for total revenue are projected at 13.76% for 2023, 48.12% for 2024, 26.16% for 2025, 22.21% for 2026, and 18.66% for 2027 [1][8] - The adjusted net profit for 2025 is projected to be 2.89 billion yuan, with a year-on-year growth of 7% [7] - The earnings per share (EPS) for 2025 is estimated at 1.06 yuan, with a P/E ratio of 27.31 [1][8] Operational Performance - The company has implemented a series of operational reforms since 2025, resulting in significant improvements in same-store performance [7] - The company's GMV in the U.S. has increased by over 50%, with same-store GMV growth of at least 20% [7]

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Views - The company reported a revenue of $8.03 billion for 2025, a year-on-year decrease of 1.8%, with a net profit attributable to shareholders of $380 million, down 2.9% year-on-year. The manufacturing business generated $5.65 billion in revenue, up 0.5% year-on-year, while the retail business saw revenue decline to $2.38 billion, down 7.0% year-on-year [1][4] - The average selling price (ASP) in the manufacturing business increased by 3.7% to $21.0, despite a slight decrease in shipment volume by 1.2% to 250 million pairs. The cautious ordering behavior from downstream brands due to tariffs and geopolitical uncertainties contributed to this decline [2] - The gross margin for the manufacturing business decreased by 1.7 percentage points to 18.2%, impacted by uneven capacity utilization and rising labor costs. However, the net profit margin improved slightly by 0.1 percentage points to 6.4% due to tax dispute reversals [3] - The retail business faced challenges with a revenue drop of 7.0% to $2.38 billion, primarily due to a decline in same-store sales and foot traffic. However, online retail showed resilience, with revenue growth exceeding 70% on platforms like Douyin [4] - The company is expected to see a recovery in demand and a return to order placement as inventory levels normalize. Revenue projections for 2026-2028 are $8.14 billion, $8.56 billion, and $9.01 billion, representing year-on-year growth rates of 1.4%, 5.1%, and 5.3%, respectively [5]